Advertisement
UK markets open in 5 hours 23 minutes

  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     

  • HANG SENG

    18,543.30
    +336.17 (+1.85%)
     

  • CRUDE OIL

    79.23
    +0.28 (+0.35%)
     

  • GOLD FUTURES

    2,312.50
    +2.90 (+0.13%)
     

  • DOW

    38,225.66
    +322.37 (+0.85%)
     

  • Bitcoin GBP

    47,389.57
    +1,879.68 (+4.13%)
     

  • CMC Crypto 200

    1,278.90
    +8.15 (+0.64%)
     

  • NASDAQ Composite

    15,840.96
    +235.48 (+1.51%)
     

  • UK FTSE All Share

    4,446.15
    +27.55 (+0.62%)
     
Money:

Best UK mortgage deals of the week

The cheapest home loans available now

Shire considering bid for NPS Pharmaceuticals - FT

Reuters - UK Focus

LONDON, May 30 (Reuters) - London-listed drugmaker Shire (Dusseldorf: S7E.DU - news) is considering a bid for New Jersey-based NPS Pharmaceuticals, FT Alphaville reported on Friday citing sources.

Shire (LSE: SHP.L - news) has been working with advisers and held internal discussions about a potential cash offer for NPS, a rare disease specialist, valuing the business at just over $4 billion, the Financial Times blog said.

Shares in Nasdaq-listed NPS were trading 15.5 percent higher at 1500 GMT giving the company a market capitalisation of $2.92 billion. Shares in Shire were trading down 1.4 percent.

(Reporting By Anjuli Davies, editing by Steve Slater)